Akinetic crisis, acute akinesia, neuroleptic malignant‐like syndrome, Parkinsonism–hyperpyrexia syndrome, and malignant syndrome are the same entity and are often independent of treatment withdrawal
Identifieur interne : 003A33 ( Main/Exploration ); précédent : 003A32; suivant : 003A34Akinetic crisis, acute akinesia, neuroleptic malignant‐like syndrome, Parkinsonism–hyperpyrexia syndrome, and malignant syndrome are the same entity and are often independent of treatment withdrawal
Auteurs : Astrid Thomas [Italie] ; Marco Onofrj [Italie]Source :
- Movement Disorders [ 0885-3185 ] ; 2005-12.
English descriptors
- KwdEn :
- MESH :
- chemical , adverse effects : Antipsychotic Agents.
- classification : Neuroleptic Malignant Syndrome.
- complications : Parkinsonian Disorders.
- etiology : Malignant Hyperthermia, Movement Disorders, Neuroleptic Malignant Syndrome.
- physiopathology : Substance Withdrawal Syndrome.
- Humans.
Abstract
A reply to this letter has been published in Movement Disorders Mov Disord (2005)DOI 10.1002/mds.20688.
Url:
DOI: 10.1002/mds.20689
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 004239
- to stream Istex, to step Curation: 004239
- to stream Istex, to step Checkpoint: 002443
- to stream PubMed, to step Corpus: 002E80
- to stream PubMed, to step Curation: 002E80
- to stream PubMed, to step Checkpoint: 003244
- to stream Ncbi, to step Merge: 001432
- to stream Ncbi, to step Curation: 001432
- to stream Ncbi, to step Checkpoint: 001432
- to stream Main, to step Merge: 005120
- to stream Main, to step Curation: 003A33
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Akinetic crisis, acute akinesia, neuroleptic malignant‐like syndrome, Parkinsonism–hyperpyrexia syndrome, and malignant syndrome are the same entity and are often independent of treatment withdrawal</title>
<author><name sortKey="Thomas, Astrid" sort="Thomas, Astrid" uniqKey="Thomas A" first="Astrid" last="Thomas">Astrid Thomas</name>
</author>
<author><name sortKey="Onofrj, Marco" sort="Onofrj, Marco" uniqKey="Onofrj M" first="Marco" last="Onofrj">Marco Onofrj</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:53C365E81B915BDDCF1E05DD8F48E6660000606C</idno>
<date when="2005" year="2005">2005</date>
<idno type="doi">10.1002/mds.20689</idno>
<idno type="url">https://api.istex.fr/document/53C365E81B915BDDCF1E05DD8F48E6660000606C/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">004239</idno>
<idno type="wicri:Area/Istex/Curation">004239</idno>
<idno type="wicri:Area/Istex/Checkpoint">002443</idno>
<idno type="wicri:doubleKey">0885-3185:2005:Thomas A:akinetic:crisis:acute</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:16149099</idno>
<idno type="wicri:Area/PubMed/Corpus">002E80</idno>
<idno type="wicri:Area/PubMed/Curation">002E80</idno>
<idno type="wicri:Area/PubMed/Checkpoint">003244</idno>
<idno type="wicri:Area/Ncbi/Merge">001432</idno>
<idno type="wicri:Area/Ncbi/Curation">001432</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">001432</idno>
<idno type="wicri:doubleKey">0885-3185:2005:Thomas A:akinetic:crisis:acute</idno>
<idno type="wicri:Area/Main/Merge">005120</idno>
<idno type="wicri:Area/Main/Curation">003A33</idno>
<idno type="wicri:Area/Main/Exploration">003A33</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Akinetic crisis, acute akinesia, neuroleptic malignant‐like syndrome, Parkinsonism–hyperpyrexia syndrome, and malignant syndrome are the same entity and are often independent of treatment withdrawal</title>
<author><name sortKey="Thomas, Astrid" sort="Thomas, Astrid" uniqKey="Thomas A" first="Astrid" last="Thomas">Astrid Thomas</name>
<affiliation wicri:level="1"><country xml:lang="fr">Italie</country>
<wicri:regionArea>Neurophysiopathology, Movement Disorders Center, Department of Oncology and Neuroscience, “Gabriele D'Annunzio” University Foundation, Chieti‐Pescara</wicri:regionArea>
<wicri:noRegion>Chieti‐Pescara</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Onofrj, Marco" sort="Onofrj, Marco" uniqKey="Onofrj M" first="Marco" last="Onofrj">Marco Onofrj</name>
<affiliation wicri:level="1"><country wicri:rule="url">Italie</country>
</affiliation>
<affiliation wicri:level="1"><country xml:lang="fr">Italie</country>
<wicri:regionArea>Neurophysiopathology, Movement Disorders Center, Department of Oncology and Neuroscience, “Gabriele D'Annunzio” University Foundation, Chieti‐Pescara</wicri:regionArea>
<wicri:noRegion>Chieti‐Pescara</wicri:noRegion>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="sub">Official Journal of the Movement Disorder Society</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2005-12">2005-12</date>
<biblScope unit="vol">20</biblScope>
<biblScope unit="issue">12</biblScope>
<biblScope unit="page" from="1671">1671</biblScope>
<biblScope unit="page" to="1671">1671</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">53C365E81B915BDDCF1E05DD8F48E6660000606C</idno>
<idno type="DOI">10.1002/mds.20689</idno>
<idno type="ArticleID">MDS20689</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antipsychotic Agents (adverse effects)</term>
<term>Humans</term>
<term>Malignant Hyperthermia (etiology)</term>
<term>Movement Disorders (etiology)</term>
<term>Neuroleptic Malignant Syndrome (classification)</term>
<term>Neuroleptic Malignant Syndrome (etiology)</term>
<term>Parkinsonian Disorders (complications)</term>
<term>Substance Withdrawal Syndrome (physiopathology)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Antipsychotic Agents</term>
</keywords>
<keywords scheme="MESH" qualifier="classification" xml:lang="en"><term>Neuroleptic Malignant Syndrome</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Parkinsonian Disorders</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Malignant Hyperthermia</term>
<term>Movement Disorders</term>
<term>Neuroleptic Malignant Syndrome</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Substance Withdrawal Syndrome</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Humans</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">A reply to this letter has been published in Movement Disorders Mov Disord (2005)DOI 10.1002/mds.20688.</div>
</front>
</TEI>
<affiliations><list><country><li>Italie</li>
</country>
</list>
<tree><country name="Italie"><noRegion><name sortKey="Thomas, Astrid" sort="Thomas, Astrid" uniqKey="Thomas A" first="Astrid" last="Thomas">Astrid Thomas</name>
</noRegion>
<name sortKey="Onofrj, Marco" sort="Onofrj, Marco" uniqKey="Onofrj M" first="Marco" last="Onofrj">Marco Onofrj</name>
<name sortKey="Onofrj, Marco" sort="Onofrj, Marco" uniqKey="Onofrj M" first="Marco" last="Onofrj">Marco Onofrj</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003A33 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003A33 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= MovDisordV3 |flux= Main |étape= Exploration |type= RBID |clé= ISTEX:53C365E81B915BDDCF1E05DD8F48E6660000606C |texte= Akinetic crisis, acute akinesia, neuroleptic malignant‐like syndrome, Parkinsonism–hyperpyrexia syndrome, and malignant syndrome are the same entity and are often independent of treatment withdrawal }}
This area was generated with Dilib version V0.6.23. |